MEDINET Co., Ltd. (TYO:2370)

Japan · Delayed Price · Currency is JPY

24.00

0.00 (0.00%)

Oct 6, 2026, 3:30 PM JST

Market Cap	6.81B -24.4%
Revenue (ttm)	998.00M -41.4%
Net Income	-3.05B
EPS	-26.77
Shares Out	283.67M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	119,300
Open	24.00
Previous Close	24.00
Day's Range	24.00 - 25.00
52-Week Range	23.00 - 43.00
Beta	0.40
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 12, 2026

About MEDINET

MEDINET Co., Ltd. operates as a contract development and manufacturing organization that provides regenerative medicine and cell therapy solutions in Japan. It operates through two segments: Cell Processing Business and Regenerative Medicine Products Business.The company’s solutions include technical know-how, facilities, systems, materials, professional cell-engineers, and other requirements to conduct immuno-cell therapy.It also manufactures regenerative medical/investigational and specified cell products. In addition, the company offers valu... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 1995

Employees 92

Stock Exchange Tokyo Stock Exchange

Ticker Symbol 2370

Full Company Profile

Financial Performance

In fiscal year 2018, MEDINET's revenue was 998.00 million, a decrease of -41.43% compared to the previous year's 1.70 billion. Losses were -3.05 billion, 17.1% more than in 2017.

Financial Statements